ABCL:NASDAQ
AbCellera Biologics Inc
$12.63
arrow_downward
-0.79%(-0.100) 1D
$12.70
arrow_upward
+0.54% (+0.069)bedtimeAfter hours
Closed: Sep 18, 4:00:01 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ABCL...
Open
$12.73
High
$12.96
Low
$12.37
Mkt. cap
4.09B
Avg. vol.
8.35M
Volume
5.44M
52-wk high
$13.18
52-wk low
$2.74
EPS
-$0.54
Beta
1.32
Shares outstanding
324.05M
No. of employees
562
Open
$12.73
High
$12.96
Low
$12.37
Mkt. cap
4.09B
Avg. vol.
8.35M
Volume
5.44M
52-wk high
$13.18
52-wk low
$2.74
EPS
-$0.54
Beta
1.32
Shares outstanding
324.05M
No. of employees
562
News stories
From web sources and news partners
Simply Wall Street
·
8 hours ago
Why AbCellera Biologics (ABCL) Is Back In The Spotlight
Profile
AbCellera Biologics Inc. is a Vancouver, British Columbia-based biotechnology company that discovers and develops antibody therapeutics. The company is best known for its leading role in the Pandemic Prevention Platform, a project of DARPA's Biological Technologies Office. AbCellera utilizes a proprietary technology platform, which they claim can develop "medical countermeasures within 60 days." Its platform for single-cell screening was initially developed at the University of British Columbia. Wikipedia
About AbCellera Biologics Inc
CEOCarl Hansen
Employees562
Founded2012
HeadquartersVancouver, British Columbia, Canada
SectorHealth care
Websiteabcellera.com